Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuball

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Leukemia|July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratioJ Versluis, F E M In 't Hout, R Devillier, et al.
Viruses|September 23, 2022
Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor CellsLaura E P Huyveneers, Anke Bruns, Arjen Stam, et al.
JCO Precision Oncology|February 17, 2022
Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete RemissionJurjen Versluis, Burak Kalin, Wendelien Zeijlemaker, et al.
Blood|January 5, 2017
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AMLBob Löwenberg, Thomas Pabst, Johan Maertens, et al.
Blood Advances|May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First RelapseNiek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Cancer Cell|December 5, 2025
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myelomaMichael Rade, David Fandrei, Markus Kreuz, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter, et al.
Leukemia|November 28, 2014
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 yearsJ J Cornelissen, J Versluis, J R Passweg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2021
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)P J Hayden, C Roddie, P Bader, et al.
Bone Marrow Transplantation|July 10, 2024
Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationJan Styczynski, Gloria Tridello, Nina Knelange, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Leukemia|July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratioJ Versluis, F E M In 't Hout, R Devillier, et al.
Viruses|September 23, 2022
Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor CellsLaura E P Huyveneers, Anke Bruns, Arjen Stam, et al.
JCO Precision Oncology|February 17, 2022
Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete RemissionJurjen Versluis, Burak Kalin, Wendelien Zeijlemaker, et al.
Blood|January 5, 2017
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AMLBob Löwenberg, Thomas Pabst, Johan Maertens, et al.
Blood Advances|May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First RelapseNiek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Cancer Cell|December 5, 2025
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myelomaMichael Rade, David Fandrei, Markus Kreuz, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter, et al.
Leukemia|November 28, 2014
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 yearsJ J Cornelissen, J Versluis, J R Passweg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2021
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)P J Hayden, C Roddie, P Bader, et al.
Bone Marrow Transplantation|July 10, 2024
Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationJan Styczynski, Gloria Tridello, Nina Knelange, et al.
Pageof 26